학술논문
Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial
Document Type
Article
Author
Source
In: The Lancet Oncology . (The Lancet Oncology, August 2022, 23(8):1009-1020)
Subject
Language
English
ISSN
14745488
14702045
14702045